Inhibikase Therapeutics

/Inhibikase Therapeutics

IPO

Inhibikase Therapeutics

Pharmaceutical

We are a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders that arise inside and outside of the brain.

Symbol

IKT

Price Range
$10.00 - $12.00

Final Shares
1,363,000

Anticipated Date
November 13, 2020

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Inhibikase Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277